Cargando…
Neoadjuvant Chemotherapy of Triple-Negative Breast Cancer: Evaluation of Early Clinical Response, Pathological Complete Response Rates, and Addition of Platinum Salts Benefit Based on Real-World Evidence
SIMPLE SUMMARY: Neoadjuvant chemotherapy (NACT) is the standard treatment for early-stage triple-negative breast cancer (TNBC). Achieving pathological complete response (pCR) is considered an essential prognostic factor with favorable long-term outcomes. The administration of NACT regimens with plat...
Autores principales: | Holanek, Milos, Selingerova, Iveta, Bilek, Ondrej, Kazda, Tomas, Fabian, Pavel, Foretova, Lenka, Zvarikova, Maria, Obermannova, Radka, Kolouskova, Ivana, Coufal, Oldrich, Petrakova, Katarina, Svoboda, Marek, Poprach, Alexandr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036281/ https://www.ncbi.nlm.nih.gov/pubmed/33808149 http://dx.doi.org/10.3390/cancers13071586 |
Ejemplares similares
-
Biomarker Dynamics and Long-Term Treatment Outcomes in Breast Cancer Patients with Residual Cancer Burden after Neoadjuvant Therapy
por: Holanek, Milos, et al.
Publicado: (2022) -
A Simple Model to Assess the Probability of Invasion in Ductal Carcinoma In Situ of the Breast Diagnosed by Needle Biopsy
por: Coufal, Oldřich, et al.
Publicado: (2014) -
Identification of AGR2 Gene-Specific Expression Patterns Associated with Epithelial-Mesenchymal Transition
por: Martisova, Andrea, et al.
Publicado: (2022) -
Incidence of Hippocampal Metastases: Laterality and Implications for Unilateral Hippocampal Avoiding Whole Brain Radiotherapy
por: Kazda, Tomas, et al.
Publicado: (2018) -
Circulating T cell subsets are associated with clinical outcome of anti-VEGF-based 1st-line treatment of metastatic colorectal cancer patients: a prospective study with focus on primary tumor sidedness
por: Bencsikova, Beatrix, et al.
Publicado: (2019)